Circulating Extracellular Vesicles from Heart Failure Patients Inhibit Human Cardiomyocyte Activities
Journal of Cardiovascular Translational Research · 2025-12 · 18 (6) · 1566-1583
DOI: 10.1007/s12265-024-10571-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Translational Research, online erschienen am 09.10.2024. Verfasst von Ke Zhen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Anzhen Hospital, Capital Medical University, Beijing, 100011, China. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Heart Failure, Extracellular Vesicles, Ventricular Remodeling. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Extracellular vesicles (EVs) have been implicated in cardiac remodeling during heart failure (HF). However, the role of circulating EVs (CEVs) in the process of HF is poorly understood. To elucidate the molecular mechanism associated with CEVs in the context of HF, the proteome of 4D label-free EVs from plasma samples was identified. Among the identified proteins, 6 exhibited upregulation while 9 demonstrated downregulation in CEVs derived from HF patients (HCEVs) compared to healthy controls (NCEVs). Our results showed that up-regulated proteins mainly participate in the primary metabolic, glycerolipid metabolic processes, oxidation-reduction process, and inflammatory amplification. In contrast, the down-regulated proteins influenced cell development, differentiation, and proliferation. Compared to NCEVs, HCEVs significantly induced inflammation and triacylglycerol (TAG) accumulation in human cardiomyocytes (HCMs) in vitro. They also compromised their regenerative capacities, triggered endoplasmic reticulum (ER) stress and increased autophagy in HCMs. Further, HCEVs induced differentiation of human cardiac fibroblasts (HCFs), amplifying pro-inflammatory, and pro-fibrotic factors, and enhancing extracellular matrix deposition. Notably, HCEVs are also associated with an increase in the HF biomarker MMP9 within HCFs and demonstrate a negative correlation with autophagic flux. In conclusion, HCEVs appear pivotal in advancing HF via pathological cardiac remodeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Anzhen Hospital, Capital Medical University, Beijing, 100011, China.
- Department of Cardiovascular Surgery, Air Force Medical Center, PLA, Beijing, 100048, China.
- Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
- The First Clinical Medical College, Hebei North University, Zhangjiakou, 075132, China.
- School of Basic Medical Sciences, Southwest Medical University, Luzhou, 646000, China.
- Center for Life Sciences, School of Life Sciences, Yunnan University, Kunming, 650500, China.
ORCID-Profile: Hongchao Zhang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhen, K., Wei, X., Zhi, Z., Shang, S., Zhang, S., Xu, Y., Fu, X., Cheng, L., Yao, J., Li, Y., Chen, X., Liu, P., & Zhang, H. (2025). Circulating Extracellular Vesicles from Heart Failure Patients Inhibit Human Cardiomyocyte Activities. Journal of Cardiovascular Translational Research, 18(6), 1566-1583. https://doi.org/10.1007/s12265-024-10571-1
Vancouver
Zhen K, Wei X, Zhi Z, Shang S, Zhang S, Xu Y, et al. Circulating Extracellular Vesicles from Heart Failure Patients Inhibit Human Cardiomyocyte Activities. Journal of Cardiovascular Translational Research. 2025;18(6):1566-1583. doi:10.1007/s12265-024-10571-1
BibTeX
@article{Zhen2025,
author = {Zhen, Ke and Wei, Xiaojuan and Zhi, Zelun and Shang, Shiyu and Zhang, Shuyan and Xu, Yilu and Fu, Xiaochuan and Cheng, Linjia and Yao, Jing and Li, Yue and Chen, Xia and Liu, Pingsheng and Zhang, Hongchao},
title = {Circulating Extracellular Vesicles from Heart Failure Patients Inhibit Human Cardiomyocyte Activities},
journal = {Journal of Cardiovascular Translational Research},
year = {2025},
volume = {18},
number = {6},
pages = {1566--1583},
doi = {10.1007/s12265-024-10571-1}
}
EUVIMED